ResearcherFox Chase Cancer CenterNo recent work listed
Lora S. Wang
Matched on OpenAlex author ID A5052761167. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2015: 1 paper · 2016: 1 paper · 2017: none · 2018: 1 paper
Papers 3
- Predictors of Hematologic Toxicity and Chemotherapy Dose Intensity in Patients Undergoing Chemoradiation for Pancreatic Cancer. First author DOI 10.1097/coc.0000000000000227↗
- Dosimetric predictors of hematologic toxicity in patients undergoing concurrent gemcitabine-based chemoradiation for localized pancreatic cancer. First author DOI 10.1016/j.prro.2015.11.005↗
- Dose escalation with a vessel boost in pancreatic adenocarcinoma treated with neoadjuvant chemoradiation. Co-author DOI 10.1016/j.prro.2015.04.004↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Talha Shaikh · 3 shared papers, 2015–2018 · strength 0.22
- Paper Predictors of Hematologic Toxicity and Chemotherapy Dose Intensity in Patients Undergoing Chemoradiation for Pancreatic… DOI 10.1097/coc.0000000000000227↗
- Paper Dosimetric predictors of hematologic toxicity in patients undergoing concurrent gemcitabine-based chemoradiation for lo… DOI 10.1016/j.prro.2015.11.005↗
- Paper Dose escalation with a vessel boost in pancreatic adenocarcinoma treated with neoadjuvant chemoradiation. DOI 10.1016/j.prro.2015.04.004↗
- John Parker Hoffman · 3 shared papers, 2015–2018 · strength 0.22
- Paper Predictors of Hematologic Toxicity and Chemotherapy Dose Intensity in Patients Undergoing Chemoradiation for Pancreatic… DOI 10.1097/coc.0000000000000227↗
- Paper Dosimetric predictors of hematologic toxicity in patients undergoing concurrent gemcitabine-based chemoradiation for lo… DOI 10.1016/j.prro.2015.11.005↗
- Paper Dose escalation with a vessel boost in pancreatic adenocarcinoma treated with neoadjuvant chemoradiation. DOI 10.1016/j.prro.2015.04.004↗
- Joshua E. Meyer · 3 shared papers, 2015–2018 · strength 0.22
- Paper Predictors of Hematologic Toxicity and Chemotherapy Dose Intensity in Patients Undergoing Chemoradiation for Pancreatic… DOI 10.1097/coc.0000000000000227↗
- Paper Dosimetric predictors of hematologic toxicity in patients undergoing concurrent gemcitabine-based chemoradiation for lo… DOI 10.1016/j.prro.2015.11.005↗
- Paper Dose escalation with a vessel boost in pancreatic adenocarcinoma treated with neoadjuvant chemoradiation. DOI 10.1016/j.prro.2015.04.004↗
- Steven J. Cohen · 3 shared papers, 2015–2018 · strength 0.22
- Paper Predictors of Hematologic Toxicity and Chemotherapy Dose Intensity in Patients Undergoing Chemoradiation for Pancreatic… DOI 10.1097/coc.0000000000000227↗
- Paper Dosimetric predictors of hematologic toxicity in patients undergoing concurrent gemcitabine-based chemoradiation for lo… DOI 10.1016/j.prro.2015.11.005↗
- Paper Dose escalation with a vessel boost in pancreatic adenocarcinoma treated with neoadjuvant chemoradiation. DOI 10.1016/j.prro.2015.04.004↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.